Status:
COMPLETED
Medical Records Review to Describe the Patterns of KRAS Testing and Vectibix Use in Europe
Lead Sponsor:
Amgen
Conditions:
Metastatic Colorectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This non-interventional retrospective medical record review study will assess the prevalence of KRAS testing and the impact of the KRAS test result on patterns of Vectibix use in patients with metasta...
Detailed Description
The medical record review will be conducted for 3 rounds in months 0, 12, and 24 after the first medical record abstraction. Before the beginning of the study, a sampling list will be created by Amgen...
Eligibility Criteria
Inclusion
- Physician
- Must be a practicing oncology specialist
- Must treat at least 5 new or continuing patients with metastatic colorectal cancer per quarter
- Must have prescribed Vectibix to treat at least 5 new or continuing patients with metastatic colorectal cancer in the past 6 months
- Physician
Exclusion
- Must be the only oncologist sampled at the same medical centre for that round of the study
- Must not have taken part in the study previously
- Patient Inclusion Criteria
- Must have received Vectibix for the treatment of metastatic colorectal cancer during the 6-month period prior to the time when medical records are obtained
- Must not have been in any experimental clinical trial at the time of receiving Vectibix
- Must provide written consent to allow access to their medical records (if local laws require it)
- Must not have taken part in the study before
Key Trial Info
Start Date :
September 19 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 2 2015
Estimated Enrollment :
439 Patients enrolled
Trial Details
Trial ID
NCT01791361
Start Date
September 19 2012
End Date
June 2 2015
Last Update
September 10 2022
Active Locations (84)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Bonheiden, Belgium, 2820
2
Research Site
Brasschaat, Belgium, 2930
3
Research Site
Bruges, Belgium, 8000
4
Research Site
Haine Saint Paul - La Louviere, Belgium, 7100